HighMark Wealth Management’s Qualigen Therapeutics QLGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $546 | Hold |
160
| – | – | ﹤0.01% | 557 |
|
|
2025
Q1 | $582 | Hold |
160
| – | – | ﹤0.01% | 520 |
|
|
2024
Q4 | $674 | Hold |
160
| – | – | ﹤0.01% | 517 |
|
|
2024
Q3 | $1.37K | Hold |
160
| – | – | ﹤0.01% | 504 |
|
|
2024
Q2 | $1.38K | Hold |
160
| – | – | ﹤0.01% | 493 |
|
|
2024
Q1 | $3.2K | Hold |
160
| – | – | ﹤0.01% | 417 |
|
|
2023
Q4 | $4.41K | Hold |
160
| – | – | ﹤0.01% | 389 |
|
|
2023
Q3 | $8.09K | Hold |
160
| – | – | 0.01% | 283 |
|
|
2023
Q2 | $7.3K | Hold |
160
| – | – | 0.01% | 301 |
|
|
2023
Q1 | $7.41K | Hold |
160
| – | – | 0.01% | 339 |
|
|
2022
Q4 | $10.3K | Hold |
160
| – | – | 0.01% | 250 |
|
|
2022
Q3 | $21K | Hold |
160
| – | – | 0.02% | 159 |
|
|
2022
Q2 | $46K | Hold |
160
| – | – | 0.04% | 107 |
|
|
2022
Q1 | $53K | Hold |
160
| – | – | 0.04% | 104 |
|
|
2021
Q4 | $86K | Hold |
160
| – | – | 0.05% | 87 |
|
|
2021
Q3 | $104K | Hold |
160
| – | – | 0.08% | 76 |
|
|
2021
Q2 | $159K | Hold |
160
| – | – | 0.12% | 56 |
|
|
2021
Q1 | $216K | Buy |
+160
| New | +$216K | 0.17% | 45 |
|